Beta Bionics, Inc. · NASDAQ:BBNX
Hopman Mark sold 275 Beta Bionics, Inc. shares (Form 4)
Traded Jun 4, 2026 · Filed Jun 5, 2026
On Jun 4, 2026, Hopman Mark (Chief Commercial Officer) sold 275 Beta Bionics, Inc. shares at US$12.31 for US$3,385 under a trading plan, leaving 130,612 shares. Filed Jun 5, 2026 (Form 4).
- Sold
- 275 shares
- Price
- US$12.31
- Value
- US$3,385
- Holding after
- 130,612 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Common Stock | Sale | 275 | US$12.31 | 130,612 | Direct |
Source
Related
- Beta Bionics, Inc.
- Hopman Mark
- Beta Bionics, Inc. shareholders
- Form 4 · Hopman Mark · Oct 16, 2026
- Form 4 · Hopman Mark · Oct 5, 2026
- Form 4/A · Hopman Mark · Sep 18, 2026
- Form 4 · Hopman Mark · Sep 17, 2026
- Form 4 · Hopman Mark · Sep 15, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Oct 7, 2026
- Form 4 · Jones Christy · Sep 23, 2026
- Form 4 · Mensinger Mike · Sep 17, 2026
- Form 4 · Hopman Mark · Sep 10, 2026
- Form 4 · Saint Sean · Sep 4, 2026